These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 20809526)
1. A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease. Bademci G; Edwards TL; Torres AL; Scott WK; Züchner S; Martin ER; Vance JM; Wang L Hum Mutat; 2010 Oct; 31(10):E1767-71. PubMed ID: 20809526 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease. Bademci G; Vance JM; Wang L CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):469-81. PubMed ID: 22583432 [TBL] [Abstract][Full Text] [Related]
3. Human tyrosine hydroxylase in Parkinson's disease and in related disorders. Nagatsu T; Nakashima A; Ichinose H; Kobayashi K J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172 [TBL] [Abstract][Full Text] [Related]
4. A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype. Haugarvoll K; Bindoff LA J Parkinsons Dis; 2011; 1(1):119-22. PubMed ID: 23939262 [TBL] [Abstract][Full Text] [Related]
5. Low frequency of GCH1 and TH mutations in Parkinson's disease. Rengmark A; Pihlstrøm L; Linder J; Forsgren L; Toft M Parkinsonism Relat Disord; 2016 Aug; 29():109-11. PubMed ID: 27185167 [TBL] [Abstract][Full Text] [Related]
6. Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease. Kunugi H; Kawada Y; Hattori M; Ueki A; Otsuka M; Nanko S Am J Med Genet; 1998 Mar; 81(2):131-3. PubMed ID: 9613851 [TBL] [Abstract][Full Text] [Related]
9. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Clot F; Grabli D; Cazeneuve C; Roze E; Castelnau P; Chabrol B; Landrieu P; Nguyen K; Ponsot G; Abada M; Doummar D; Damier P; Gil R; Thobois S; Ward AJ; Hutchinson M; Toutain A; Picard F; Camuzat A; Fedirko E; Sân C; Bouteiller D; LeGuern E; Durr A; Vidailhet M; Brice A; Brain; 2009 Jul; 132(Pt 7):1753-63. PubMed ID: 19491146 [TBL] [Abstract][Full Text] [Related]
10. Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease. Hertz JM; Ostergaard K; Juncker I; Pedersen S; Romstad A; Møller LB; Güttler F; Dupont E Eur J Neurol; 2006 Apr; 13(4):385-90. PubMed ID: 16643317 [TBL] [Abstract][Full Text] [Related]
11. Current status of tyrosine hydroxylase in management of Parkinson's disease. Feve AP CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428 [TBL] [Abstract][Full Text] [Related]
12. GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism. Nagatsu T; Ichinose H Neurochem Res; 1996 Feb; 21(2):245-50. PubMed ID: 9182249 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects. Nagatsu T; Nagatsu I J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309 [TBL] [Abstract][Full Text] [Related]
14. Overview of tyrosine hydroxylase in Parkinson's disease. Zhu Y; Zhang J; Zeng Y CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):350-8. PubMed ID: 22483316 [TBL] [Abstract][Full Text] [Related]
15. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency. Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013 [TBL] [Abstract][Full Text] [Related]
16. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro]. Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408 [TBL] [Abstract][Full Text] [Related]
17. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Lüdecke B; Knappskog PM; Clayton PT; Surtees RA; Clelland JD; Heales SJ; Brand MP; Bartholomé K; Flatmark T Hum Mol Genet; 1996 Jul; 5(7):1023-8. PubMed ID: 8817341 [TBL] [Abstract][Full Text] [Related]
18. Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Bräutigam C; Steenbergen-Spanjers GC; Hoffmann GF; Dionisi-Vici C; van den Heuvel LP; Smeitink JA; Wevers RA Clin Chem; 1999 Dec; 45(12):2073-8. PubMed ID: 10585338 [TBL] [Abstract][Full Text] [Related]
19. The function of tyrosine hydroxylase in the normal and Parkinsonian brain. Tolleson C; Claassen D CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):381-6. PubMed ID: 22483314 [TBL] [Abstract][Full Text] [Related]